Search research articles
Contact Us
Filters
Showing results (101-110 of 102) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 102 results.
Journal of Medicinal Chemistry
|
August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy
Marvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 23, 2021
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial
Aaron Winkler, Weiyong Sun, Saurav De, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 102) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 102 results.
Journal of Medicinal Chemistry
|
August 3, 2010
Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy
Marvin J Meyers, Graciela B Arhancet, Susan L Hockerman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 23, 2021
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial
Aaron Winkler, Weiyong Sun, Saurav De, et al.
Page
of 11